IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Orbimed Advisors LLC

Portfolio Profile

CIK: 0001055951 | New York, NY

Investment Profile

Style

Growth

Turnover

Medium

Orientation

Concentrated trader
$5.3B
AUM
121
Positions
43.03%
Top 10 Conc.
64.18%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Edgewise Therapeutics Inc(EWTX)15,518,492$630.5M11.68%
2Enliven Therapeutics Inc(ELVN)6,776,632$343.9M6.37%
3ELI Lilly & Co(LLY)257,900$309.3M5.73%
4MBX Biosciences Inc(MBX)3,428,736$189.3M3.51%
5Sinovac Biotech LTD(SVA)2,718,735$184.5M3.42%

Sector Allocation

Latest filing, equity positions only

Healthcare92.34% · $4.9B
Unclassified7.66% · $404.4M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare94.24%92.34%-1.9%
Unclassified5.76%7.66%+1.9%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$4.7B | 128 pos.
$5.0B | 111 pos.
$5.5B | 115 pos.
$5.1B | 115 pos.
$5.5B | 119 pos.
$4.9B | 119 pos.
6
Astrazeneca PLC(AZN)
915,700
$171.1M
3.17%
7Structure Therapeutics Inc(GPCR)2,209,400$118.6M2.20%
8Sionna Therapeutics Inc(SION)2,555,877$112.4M2.08%
9Corvus Pharmaceuticals Inc(CRVS)7,165,006$107.0M1.98%
10Arrivent Biopharma Inc(AVBP)3,027,328$105.2M1.95%
Cap SizePrev %Curr %Change
Mid Cap27.23%31.62%+4.39%
Small Cap32.58%28.3%-4.28%
Large Cap20.62%15.95%-4.67%
Mega Cap9.37%11.98%+2.61%
Unclassified5.76%7.66%+1.9%
Micro Cap4.44%4.48%+0.04%
$4.2B | 111 pos.
$4.0B | 103 pos.
$4.3B | 110 pos.
$4.9B | 108 pos.
$5.0B | 114 pos.
$5.4B | 129 pos.
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

42
New
25
Closed
32
Increased
27
Decreased
28
Unchanged